Greystone-Housing-Impact-Investors_Logo_Horizontal_Green for NYSE.jpg
Greystone Housing Impact Investors LP Increases Line of Credit to $50 Million
March 06, 2024 16:15 ET | Greystone Housing Impact Investors LP
OMAHA, Neb., March 06, 2024 (GLOBE NEWSWIRE) -- Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced today that on March 4, 2024, it closed on a $10 million increase in...
RNAZ White background cropped.jpg
TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress
March 06, 2024 16:15 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress
neogames-logo.png
NeoGames Announces Fourth Quarter and Full Year 2023 Results
March 06, 2024 16:15 ET | NeoGames SA
– Full Year 2023 Revenues and Share of NPI Revenues Interest total $254.6 million –– Full Year 2023 Net Loss of $18.3 million and Adjusted Net Income, after taking effect of the amortization of Aspire...
Nanobiotix logo.jpg
Nanobiotix to Present at Upcoming Investor Conferences in March
March 06, 2024 16:15 ET | Nanobiotix S.A.
PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based...
omegaflex logo.jpg
Omega Flex, Inc. Announces Fourth Quarter 2023 Earnings
March 06, 2024 16:15 ET | Omega Flex, Inc.
  OMEGA FLEX, INC. (OFLX)  For the Period Ended December 31,  Twelve Months Three Months            2023  2022  2023  2022         Net...
Kronos Letterhead Logo.jpg
KRONOS WORLDWIDE, INC. REPORTS FOURTH QUARTER 2023 RESULTS
March 06, 2024 16:15 ET | Kronos Worldwide
Dallas, Texas, March 06, 2024 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $5.3 million, or $.05 per share, in the fourth quarter of 2023 compared to a net loss...
IO Biotech.jpg
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 06, 2024 16:11 ET | IO Biotech
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Zymeworks Logo_color.png
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024 16:09 ET | Zymeworks Inc.
Reported $456.3 million in cash resources as of December 31, 2023, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Initiation of...
l-odca295.jpg
Oil-Dri Board of Directors Declares Quarterly Dividends
March 06, 2024 16:08 ET | Oil-Dri Corporation Of America
CHICAGO, March 06, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Oil-Dri Corporation of America (NYSE: ODC) today declared quarterly cash dividends of $0.29 per share of the Company’s Common...
Cohen & Company.jpg
Cohen & Company Reports Fourth Quarter & Full Year 2023 Financial Results
March 06, 2024 16:05 ET | Cohen & Company Inc.
Fourth Quarter Net Income Attributable to Cohen & Company Inc. of $4.5 Million, or $2.97 per Diluted Share Fourth Quarter Adjusted Pre-Tax income of $16.0 Million, or $2.88 per Diluted Share ...